POAI Logo 011319 (002).jpg
Predictive Oncology Inc. Announces Newest Board Member
27 avr. 2021 08h30 HE | Predictive Oncology Inc.
MINNEAPOLIS, April 27, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology Inc. Announces New CEO
23 mars 2021 08h30 HE | Predictive Oncology Inc.
MINNEAPOLIS, March 23, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug...
POAI Logo 011319 (002).jpg
Predictive Oncology Reports Year End 2020 Financial Results, Provides Business Update
15 mars 2021 17h15 HE | Predictive Oncology Inc.
MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) – Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”)...
POAI Logo 011319 (002).jpg
Predictive Oncology’s, Skyline Medical Division, Developing Generation 3 Direct-to-Drain Automated Fluid Waste Management System
08 mars 2021 08h30 HE | Predictive Oncology Inc.
MINNEAPOLIS, March 08, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
POAI Logo 011319 (002).jpg
POAI ‘s Helomics Division Announces Progress on Milestones for its AI-Driven Model of Ovarian Cancer
24 févr. 2021 08h30 HE | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
POAI Logo 011319 (002).jpg
Predictive Oncology Announces Closing of $17.6 Million Private Placement Priced At-the-Market
23 févr. 2021 17h30 HE | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
POAI Logo 011319 (002).jpg
Predictive Oncology Announces $17.6 Million Private Placement Priced At-the-Market
18 févr. 2021 09h00 HE | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
POAI Logo 011319 (002).jpg
Two Top Researchers find Breakthrough Discoveries using Predictive Oncology’s Wholly Owned Subsidiary, TumorGenesis’s Technology
17 févr. 2021 08h30 HE | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
POAI Logo 011319 (002).jpg
Predictive Oncology Announces Closing of $7.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
16 févr. 2021 17h00 HE | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
POAI Logo 011319 (002).jpg
Predictive Oncology Announces $7.4 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
11 févr. 2021 00h30 HE | Predictive Oncology Inc.
MINNEAPOLIS, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...